Zobrazeno 21 - 30
of 115
pro vyhledávání: '"Javier Lopez-Jimenez"'
Autor:
Kyra Velázquez-Kennedy, Valentín García-Gutiérrez, Miguel Piris-Villaespesa, Javier Lopez Jimenez, Claudia Nunez-Torron, Alejandro Luna, Gemma Moreno Jiménez, Anabelle Chinea, Carlos Jimenez Chillon, Adolfo Saez, Juan Marquet Palomanes, Fernando Martin Moro, Pilar Herrera
Publikováno v:
Blood. 138:3931-3931
Introduction: Response to chemotherapy treatment both by cytology and by more sensitive techniques such as cytometry is one of the most influential parameters in the survival of patients with Acute Myeloid Leukaemia (AML). Patients with detectable mi
Autor:
Maria-Victoria Mateos, Joaquin Martinez Lopez, Paula Rodríguez-Otero, Veronica Gonzalez-Calle, Marta Sonia Gonzalez, Albert Oriol, Norma C. Gutierrez, Rafael Rios, Laura Rosinol, Miguel Angel Alvarez, Joan Bargay, Ana Pilar Gonzalez, Adrian Alegre, Fernando Escalante, Belén Iñigo, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro Hernández, Javier Lopez Jimenez, Aránzazu García Mateo, Marta Reinoso Segura, Enrique Ocio, Bruno Paiva, Noemi Puig, María Teresa Cedena, Joan Bladé, Juan Jose Lahuerta, Jesús F. San-Miguel
Publikováno v:
Blood. 138:1829-1829
Introduction: SMM is an asymptomatic plasma cell disorder with heterogeneous clinical behavior. Both the Spanish Myeloma and ECOG Groups have demonstrated that patients (pts) at high risk of progression to active MM have prolonged time-to progression
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mónica García-Cosío, Javier Lopez Jimenez, José A. García-Marco, Eulalia Rodríguez Martín, Fernando Martin Moro, Ernesto Roldan Santiago, Federico Santiago Herrera, Miguel Piris-Villaespesa, Juan Marquet Palomanes, Alberto Martinez Lorca, Maria Isabel Delgado Trillo, Jose Antonio Garcia Vela, Claudia Lopez Prieto, Ana Lario Arribas
Publikováno v:
Blood. 136:33-34
Introduction Bone marrow (BM) examination at diffuse large B-cell lymphoma (DLBCL) diagnosis is essential in staging and has prognostic implication. According to the last recommendations (Cheson, et al. JCO 2014) BM biopsy (BMB) is only needed for th
Autor:
Lucía Rubio, Claudia Nunez-Torron, Miguel Piris-Villaespesa, Anabelle Chinea, Javier Lopez Jimenez, Alejandro Luna, Valentín García-Gutiérrez, Pilar Herrera Puente, Ana Lario, Maria Eulalia Rodriguez, Fernando Martin Moro, Juan Marquet Palomanes, Adolfo Saez, Ernesto Roldan, Gemma Moreno Jiménez
Publikováno v:
Blood. 136:15-16
Introduction: Patients with Acute Myeloid Leukemia (AML) and positive Minimal Residual Disease (MRD) prior to allogeneic transplant are currently considered to be a group at high risk of relapse. Multiparameter flow cytometry is a standard technique
Autor:
Alejandro Luna, Valentín García-Gutiérrez, Gemma Moreno Jiménez, Adolfo Saez, Javier Lopez Jimenez, Jesús Villarrubia, Juan Marquet Palomanes, Claudia Nunez-Torron, Pilar Herrera Puente
Publikováno v:
Blood. 136:30-31
Introduction: In the WHO 2016 classification, within the category of Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC), 3 subgroups are distinguished: 1) AML with Defining Cytogenetic Abnormality (AML-DCA) 2) AML with Previous Hist
Autor:
Valentín García-Gutiérrez, Juan Marquet Palomanes, Claudia Nunez-Torron, Pilar Herrera Puente, Berta Mercedes Michael Fernández, Adolfo Saez, Gemma Moreno Jiménez, Miguel Piris-Villaespesa, Irene Garcia-Garcia, Javier Lopez Jimenez, Jesús Villarrubia
Publikováno v:
Blood. 136:34-35
Introduction: Among Therapy-Related Myeloid Neoplasms (t-MNs), there are two large groups depending on the cytotoxic trigger. A first group arises after exposure to alkylating agents and / or radiation in the previous 5-10 years and it is associated
Autor:
Samuel Romero, Ana Marin Niebla, Jose Luis Bello, Maria J. Rodriguez-Salazar, Itziar Oiartzabal, Jose Javier Sanchez Blanco, Pablo Mozas, José-Ángel Hernández, Juan-Manuel Sancho, Santiago Mercadal, Pascual Fernandez Abellan, Ana Muntañola Prat, Ana Lafuente, Alejandro Martín, López Guillermo Armando, Marc Sorigue, Angel Ramirez Payer, Beatriz Cuevas, Javier Lopez Jimenez, Olga García, Nicholas Kelleher, Raul Cordoba, Eva Donato
Publikováno v:
Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background and objective. Idelalisib is an oral inhibitor of the p110δ isoform of PI3K (phosphoinositide 3-kinase) approved in Europe and USA as monotherapy in relapsed/refractory follicular lymphoma (FL) after 2 previous lines of therapy based on a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523a9868c99d64bc2d1c2f6f8e9df60d
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2819
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2819
Autor:
Aránzazu García-Mateo, Paula Rodriguez-Otero, María Teresa Cedena, M A Alvarez, Joaquin Martinez Lopez, Albert Oriol, Joan Bladé, Jesús F. San Miguel, Laura Rosiñol, Rafael Rios, Javier Lopez Jimenez, Miguel T. Hernandez, Ana Isabel Teruel, Marta González, Esther Piensa, Joan Bargay, Maria-Victoria Mateos, Fernando Escalante, Veronica D. Gonzalez, Javier de la Rubia, Ana Pilar Gonzalez, Jesús Martín, Felipe de Arriba, Bruno Paiva, María José Calasanz, Noemi Puig, Norma C. Gutiérrez, Rafael Martínez, Juan José Lahuerta, Enrique M. Ocio, Luis Palomera
Publikováno v:
Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Introduction: Smoldering Multiple Myeloma (SMM) is an asymptomatic plasma cell disorder that includes patients with different risk of progression to Multiple Myeloma (MM). The Spanish Myeloma Group demonstrated that early treatment with Rd versus obs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8198cbc468a0bc825cdd6ddd8a79a70
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3726
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3726
Autor:
Jesús Fortún, Elia Gómez-García de la Pedrosa, Alberto Martínez-Lorca, Patricia Paredes, Pilar Martín-Dávila, Alicia Gómez-López, María José Buitrago, Javier López-Jiménez, Francesca Gioia, Rosa Escudero, Maria Elena Alvarez-Alvarez, Cruz Soriano, Javier Moreno-García, Diana San Miguel, Noelia Vicente, Santiago Moreno
Publikováno v:
Journal of Fungi, Vol 10, Iss 3, p 191 (2024)
Although nebulized liposomal amphotericin B (NLAB) is being used in invasive pulmonary aspergillosis (IPA) prophylaxis, no clinical trial has shown its efficacy as a therapeutic strategy. NAIFI is the inaugural randomized, controlled clinical trial d
Externí odkaz:
https://doaj.org/article/55f00a22f62d40f292788955aec4af09